Date: 2/19/2008Length: 00:15:01
Size: 6.87MB
Thought Leader: Maria Kempshall, Head of Regulatory Affairs and Quality Assurance, IDIS
This is the second of three IDIS sponsored Podcasts covering named patient programs. In this episode, Ms. Kempshall gives a brief overview on the topic and then provides a detailed discussion on key regulatory issues, factors impacting pharmacovigilance, and finally, how to communicate the availability of a named patient program.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
No comments:
Post a Comment